Amicus Started at Buy by Jefferies, Viewed as "Growth at Reasonable Price"

Seeking AlphaSep 7 00:49

J&J Submits FDA Application for Myasthenia Gravis Drug Nipocalimab

Seeking AlphaAug 29 23:49

Cantor Fitzgerald Reiterates Overweight on Krystal Biotech

BenzingaAug 29 23:00

Evercore ISI Group Maintains Outperform on Avidity Biosciences, Lowers Price Target to $53

BenzingaAug 26 21:14 · Ratings

These Are the Stocks With the Largest Changes in Short Interest in July - GS

Seeking AlphaAug 22 02:51

JP Morgan Maintains Overweight on Amicus Therapeutics, Lowers Price Target to $16

BenzingaAug 16 20:07 · Ratings